Skip to main content
. 2013 Jun 4;305(4):E465–E474. doi: 10.1152/ajpendo.00245.2013

Fig. 5.

Fig. 5.

Top: glucose infusion rate required to maintain target glucose concentrations (∼10 mM) during [1-13C]acetate infusion in healthy (□) and T2DM subjects (▲) and [U-13C]glycerol infusion in healthy subjects (gray squares). Bottom: plasma [3-3H]glucose-specific activity during [1-13C]acetate infusion in healthy (□) and T2DM subjects (▲) and [U-13C]glycerol infusion in healthy subjects (gray squares).